Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia.
作者： Uri S. Alon , René G. VanDeVoorde
DOI: 10.1007/S00467-010-1547-5
关键词: Medicine 、 Calcium-sensing receptor 、 Endocrinology 、 Gastroenterology 、 Nephrology 、 Familial hypocalciuric hypercalcemia 、 Parathyroid hormone 、 Internal medicine 、 Calcium metabolism 、 Cinacalcet 、 Tissue healing 、 Surgical scar
摘要: We describe a child with familial hypocalciuric hypercalcemia (FHH) in whom the seemed to interfere tissue healing after tympanoplasty. Consequently, he was placed on cinacalcet (30 mg/day), changed 2 weeks 60 mg/day. The treatment resulted decrease serum parathyroid hormone (PTH) from 148 32 pg/mL (normal 7–75) and ionized calcium 1.48 1.23 mmol/L (1.13–1.34), as well successful of revised surgical scar. Over 12-month period no complications were noted. conclude that may be considered new, currently only, tool treating children symptomatic FHH.
springer.com
sci-hub.se 参考文章(18)
L. Darryl Quarles, Extracellular calcium-sensing receptors in the parathyroid gland, kidney, and other tissues. Current Opinion in Nephrology and Hypertension. ,vol. 12, pp. 349- 355 ,(2003) , 10.1097/00041552-200307000-00002
Eberhard Ritz, Calcimimetics--fooling the calcium receptor. Pediatric Nephrology. ,vol. 20, pp. 15- 18 ,(2005) , 10.1007/S00467-004-1671-1
Jutta Muscheites, Marianne Wigger, Erdmute Drueckler, Dagmar-Christiane Fischer, Guenther Kundt, Dieter Haffner, Cinacalcet for secondary hyperparathyroidism in children with end-stage renal disease Pediatric Nephrology. ,vol. 23, pp. 1823- 1829 ,(2008) , 10.1007/S00467-008-0810-5
S. H. S. Pearce, C. Wooding, M. Davies, S. E. Tollefsen, M. P. Whyte, R. V. Thakker, Calcium-sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pancreatitis. Clinical Endocrinology. ,vol. 45, pp. 675- 680 ,(1996) , 10.1046/J.1365-2265.1996.750891.X
B. Festen-Spanjer, C. M. Haring, J. B. Koster, A. H. Mudde, Correction of hypercalcaemia by cinacalcet in familial hypocalciuric hypercalcaemia Clinical Endocrinology. ,vol. 68, pp. 324- 325 ,(2007) , 10.1111/J.1365-2265.2007.03027.X
Edward M. Brown, Gerardo Gamba, Daniela Riccardi, Michael Lombardi, Robert Butters, Olga Kifor, Adam Sun, Matthias A. Hediger, Jonathan Lytton, Steven C. Hebert, Cloning and characterization of an extracellular Ca 2+ -sensing receptor from bovine parathyroid Nature. ,vol. 366, pp. 575- 580 ,(1993) , 10.1038/366575A0
A. Gal-Moscovici, S.M. Sprague, The role of calcimimetics in chronic kidney disease Kidney International. ,vol. 70, ,(2006) , 10.1038/SJ.KI.5001982
H. J. L. M. TIMMERS, M. KARPERIEN, N. A. T. HAMDY, H. DE BOER, A. R. M. M. HERMUS, Normalization of serum calcium by cinacalcet in a patient with hypercalcaemia due to a de novo inactivating mutation of the calcium-sensing receptor. Journal of Internal Medicine. ,vol. 260, pp. 177- 182 ,(2006) , 10.1111/J.1365-2796.2006.01684.X
Ramona Rus, Christine Haag, Christiane Bumke-Vogt, Volker Bähr, Bernhard Mayr, Matthias Möhlig, Egbert Schulze, Karin Frank-Raue, Friedhelm Raue, Christof Schöfl, Novel inactivating mutations of the calcium-sensing receptor: the calcimimetic NPS R-568 improves signal transduction of mutant receptors. The Journal of Clinical Endocrinology and Metabolism. ,vol. 93, pp. 4797- 4803 ,(2008) , 10.1210/JC.2008-1076
Dolores M. Shoback, John P. Bilezikian, Stewart A. Turner, Laura C. McCary, Matthew D. Guo, Munro Peacock, The Calcimimetic Cinacalcet Normalizes Serum Calcium in Subjects with Primary Hyperparathyroidism The Journal of Clinical Endocrinology and Metabolism. ,vol. 88, pp. 5644- 5649 ,(2003) , 10.1210/JC.2002-021597